A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis

Area of Science:

• Neuroimmunology
• Hematology
• Regenerative Medicine

Background:

• Multiple sclerosis (MS) is a central nervous system inflammatory disorder primarily affecting young adults.
• While treatments have advanced, some MS patients remain unresponsive to standard therapies.
• Autologous hematopoietic stem cell transplantation (aHSCT) is an emerging option for refractory MS.

Purpose of the Study:

• To establish a standardized protocol for aHSCT in multiple sclerosis.
• To facilitate consistent data registration for aHSCT in MS patients.
• To provide a consensus guideline for a Belgian working party on stem cell therapy.

Main Methods:

• Development of a consensus protocol by a dedicated working party.
• Focus on standardized procedures for aHSCT in the context of MS.
• Inclusion of data registration guidelines.

Main Results:

• A consensus protocol for aHSCT in multiple sclerosis has been established.
• The protocol aims to standardize the procedure and improve data collection.
• This represents a collaborative effort to refine a treatment option for refractory MS.

Conclusions:

• The developed protocol provides a standardized approach to aHSCT for multiple sclerosis.
• This initiative aims to improve outcomes and facilitate research in aHSCT for MS.
• The consensus protocol addresses the growing patient interest in this therapeutic option.